The $54.5 billion in vitro diagnostics market was divided up by ten giants.
Based on data from 120 companies in the industry, EvaluateMedTech predicts that global sales of medical technology (including medical devices and diagnostic products) will reach $440 billion billion by 2018, a growth rate of 4.4 percent. The segment with the largest market share is IVD, which is expected to account for 12.4 percent of the total market in 2018, reaching $54.5 billion billion.
Statistics show that by 2018, the total annual sales of these ten giant companies will reach 44.5 billion US dollars, with an average growth rate of 5%. Total sales accounted for 81.6 per cent of the total market share, up 4 percentage points from 2011 statistics. 1. Data interpretation
The IVD industry with unlimited market potential and rapid development momentum is currently the most dynamic sub-industry in China's medical device industry, but its international competition is extremely fierce. It can be seen from the above table data:
First, the world's top 10 IVD giants, Central Europe and the United States, have nine seats, while the United States has six seats.
The world's top 10 companies have six in the United States; one in Germany; one in France; one in Switzerland; and one in Japan. Basically in countries with strong economies and manufacturing industries. Compared with China's IVD enterprises, these ten giant enterprises also have a long history of development and product and market accumulation. They belong to the leading technology and comprehensive products in the industry, and occupy a very obvious first mover advantage in the market competition.
Second, the market share of the top ten enterprises is gradually increasing, and the market monopoly is further deepened.
Relying on its advanced technology and comprehensive products and brand inheritance, the top ten giant companies take the lead in seizing market opportunities, and at the same time continue to expand themselves through mergers and acquisitions and other means to dominate the world market. Data for 2011 show that the total sales of 10 enterprises accounted for 77.6 percent, and is expected to grow at an average growth rate of 5 percent. By 2018, the total sales share will further climb to 81.6 percent, with 10 enterprises accounting for as much as 80 percent of the entire market-the entire IVD market will enter an era of monopoly.
Three is: "one super many strong" situation
Roche, which ranks first, occupies nearly 20% of the global market share with sales of nearly 10 billion US dollars, showing Roche's strong dominance in IVD. Danaher (Beckman Coulter), Siemens and Abbott have become the top three after Roche with a market share of about 10%, while the remaining six enterprises have a market share of less than 10% respectively.
2. Analysis of domestic IVD industry
At present, although domestic IVD enterprises have great growth in quantity, scale and technology, and the market share rate has also made great progress, imported IVD reagents still occupy a large market in the domestic market, especially in tertiary hospitals. Domestic brands are still facing fierce competition.
There are many domestic IVD enterprises, but they have not formed the same volume as the top ten giants in terms of scale. Although some enterprises reach or even lead the foreign giants in technology, they are far from each other in terms of product richness and cannot be compared with them in terms of brand establishment and promotion.
Although the domestic IVD field is very hot, technology and capital inflows are very large, but most of the enterprises are still in the stage of "small trouble" and can not be gathered into a scale; in terms of brand building, the domestic popularity is not high, and it is impossible to compete with these giant enterprises in the world.
The realistic gap is that domestic IVD enterprises have missed the first-mover advantage of gold development, and how to maximize the late-mover advantage has become the most concerned issue in the industry.
Under the premise of mastering advanced technology, how to set up a competitive company with rich products and large volume requires the cooperation of policies, capital, technology, talents and other resources. Perhaps the sudden emergence of the film industry will give some inspiration to the IVD field. In short, the development of domestic IVD industry still has a long way to go.